EARNINGS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2019

Schedule of Earnings Per Share, Basic and Diluted

The components of basic and diluted earnings per share are as follows:



	For The Year Ended December 31,
	2019			2018			2017
Income from continuing operations	$	119,208		$	97,065		$	51,063
Net (income) / loss attributable to noncontrolling interests	(74		)	79			341
Less: preferred share accretion paid in kind (Note 13)	—			(4,777		)	(9,694		)
Less: income allocated to Series B Preferred Shares	(35,237		)	(29,956		)	(16,994		)
Income / (loss) from continuing operations available to common shareholders, net of noncontrolling interest	83,897			62,411			24,716
Income / (loss) from discontinued operations, net of tax	—			60,548			(1,636		)
Less: (income) / loss allocated to Series B Preferred Shares	—			(19,637		)	667
Net income attributable to CME Ltd. available to common shareholders — basic	83,897			103,322			23,747

Effect of dilutive securities
Dilutive effect of employee stock options, RSUs and common stock warrants	148			3,653			3,829
Net income attributable to CME Ltd. available to common shareholders — diluted	$	84,045		$	106,975		$	27,576

Weighted average outstanding shares of common stock — basic ⁽¹⁾	264,611			230,562			155,846
Dilutive effect of employee stock awards and common stock warrants	1,587			27,132			80,558
Weighted average outstanding shares of common stock — diluted	266,198			257,694			236,404

Net income / (loss) per share:
Continuing operations — basic	$	0.32		$	0.27		$	0.16
Continuing operations — diluted	0.32			0.25			0.12
Discontinued operations — basic	—			0.18			(0.01		)
Discontinued operations — diluted	—			0.17			0.00
Attributable to CME Ltd. — basic	0.32			0.45			0.15
Attributable to CME Ltd. — diluted	0.32			0.42			0.12

⁽¹⁾

For the purpose of computing basic earnings per share, the 11,211,449 shares of Class A common stock underlying the Series A Preferred Share are included in the weighted average outstanding shares of common stock - basic, because the rights of the Series A Preferred Share are considered substantially similar to that of our Class A common stock.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

eighted-average, equity awards and convertible shares are excluded from the calculation of diluted earnings per share if their effect would be anti-dilutive. The following instruments were anti-dilutive for the periods presented, but may be dilutive in future periods:



	For The Year Ended December 31,
	2019	2018	2017
RSUs	376	1,506	144
Total	376	1,506	144

These instruments may become dilutive in the future. As set forth in the Certificate of Designation for the Series B Preferred Shares, the holders of our Series B Preferred Shares are not contractually obligated to share in our losses.